Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "NIT"

5814 News Found

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students
Policy | February 22, 2024

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students

We are achieving the target of developed India by making our young children healthy today


Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP
Drug Approval | February 17, 2024

Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP

Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)


Aparna Group forays into pharma business; Receives USFDA clearance for manufacturing unit
News | February 15, 2024

Aparna Group forays into pharma business; Receives USFDA clearance for manufacturing unit

The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies


American Cancer Society and Pfizer announce a US $15 million initiative to bridge the gap in cancer care disparities
Healthcare | February 07, 2024

American Cancer Society and Pfizer announce a US $15 million initiative to bridge the gap in cancer care disparities

The initiative, “Change the Odds: Uniting to Improve Cancer Outcomes” aims to enhance awareness of and access to cancer screening, clinical trials and support


Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
Drug Approval | January 28, 2024

Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana

The company intends to respond to the two minor observations within the stipulated time


NITI Aayog organises workshop on ‘Strengthening Mental Health Services and Care in India’
Policy | January 12, 2024

NITI Aayog organises workshop on ‘Strengthening Mental Health Services and Care in India’

The workshop was conducted as a part of the NITI–State workshop series


Merck announces Phase 3 trial initiations for 4 Investigational Candidates from hematology and oncology pipeline
Clinical Trials | January 06, 2024

Merck announces Phase 3 trial initiations for 4 Investigational Candidates from hematology and oncology pipeline

Comprehensive clinical development programs being initiated for each investigational candidate


Strides Pharma Science extends guarantee to Trinity Pharma Proprietary’s borrowing
News | December 22, 2023

Strides Pharma Science extends guarantee to Trinity Pharma Proprietary’s borrowing

Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore


Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease
Drug Approval | December 18, 2023

Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease

Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation


Merck and Moderna initiate Phase 3 study evaluating V940 (mRNA-4157) in combination with Keytruda for treatment of non-small cell lung cancer
News | December 12, 2023

Merck and Moderna initiate Phase 3 study evaluating V940 (mRNA-4157) in combination with Keytruda for treatment of non-small cell lung cancer

The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)